(E, E) -Farnesol-d6
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


(E, E) -Farnesol-d6
Description :
(E, E) -Farnesol-d6 (trans, trans-Farnesol-d6) is deuterium labeled (E, E) -Farnesol (HY-Y0248) . (E, E) -Farnesol (trans, trans-Farnesol) is a quorum-sensing molecule of Candida species. (E, E) -Farnesol can inhibit the growth, metabolism and biofilm formation of various Candida species, and affect their morphology and invasiveness[1][2].CAS Number :
[166447-71-8]Product Name Alternative :
Trans, trans-Farnesol-d6; (2E,6E) -Farnesol-d6UNSPSC :
12352211Hazard Statement :
H302-H315-H319-H335Target :
Fungal; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
Anti-infection; OthersApplications :
COVID-19-immunoregulationField of Research :
InfectionPurity :
98.56Solubility :
10 mM in DMSOSmiles :
OC/C=C(C)/CC/C=C(C)/CC/C=C(C([2H])([2H])[2H])/C([2H])([2H])[2H]Molecular Formula :
C15H20D6OMolecular Weight :
228.40Precautions :
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-217.|[2]Cordeiro Rde A, et al. Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes. Vet Microbiol. 2012 Oct 12;159 (3-4) :375-80.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development Reported

